世界の血液脳関門輸送薬市場レポート2020年

QYResearchが発行した調査報告書(QYR21FB2014)
◆英語タイトル:Global Blood-Brain Barrier Transport Drugs Sales Market Report 2020
◆商品コード:QYR21FB2014
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:141
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の血液脳関門輸送薬市場について種類別(担体輸送、受容体輸送、吸収性輸送、能動排出輸送、その他)、用途別(アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳腫瘍、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・血液脳関門輸送薬市場の概要
・世界の主要地域別血液脳関門輸送薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の血液脳関門輸送薬市場規模2015-2026:種類別(担体輸送、受容体輸送、吸収性輸送、能動排出輸送、その他)
・世界の血液脳関門輸送薬市場規模2015-2026:用途別(アルツハイマー病、てんかん、パーキンソン病、多発性硬化症、ハンター症候群、脳腫瘍、その他)
・血液脳関門輸送薬のアメリカ市場規模2015-2020
・血液脳関門輸送薬のヨーロッパ市場規模2015-2020
・血液脳関門輸送薬の中国市場規模2015-2020
・血液脳関門輸送薬の日本市場規模2015-2020
・血液脳関門輸送薬の東南アジア市場規模2015-2020
・血液脳関門輸送薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・血液脳関門輸送薬の製造コスト分析
・販売チャネル、流通業者、顧客
・血液脳関門輸送薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Blood-Brain Barrier Transport Drugs Market
The global Blood-Brain Barrier Transport Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Blood-Brain Barrier Transport Drugs Scope and Market Size
The global Blood-Brain Barrier Transport Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood-Brain Barrier Transport Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Blood-Brain Barrier Transport Drugs market is segmented into
Carrier-mediated Transport
Receptor-mediated Transport
Absorptive-mediated Transport
Active Efflux Transport
Others

Segment by Application, the Blood-Brain Barrier Transport Drugs market is segmented into
Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Others

The Blood-Brain Barrier Transport Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Blood-Brain Barrier Transport Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Blood-Brain Barrier Transport Drugs Market Share Analysis
Blood-Brain Barrier Transport Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Blood-Brain Barrier Transport Drugs business, the date to enter into the Blood-Brain Barrier Transport Drugs market, Blood-Brain Barrier Transport Drugs product introduction, recent developments, etc.

The major vendors covered:
Cyclenium
BioAdvance
EIP Pharma
Bioasis
Immune Pharmaceuticals
AZ Therapies
Palobiofarma
Bach Pharma
BrainsGate
CarThera
Dainippon Sumitomo Pharma
Fluorinov Pharma
Fondazione Telethon
Minoryx
NewGen Therapeutics

【レポートの目次】

1 Blood-Brain Barrier Transport Drugs Market Overview
1.1 Blood-Brain Barrier Transport Drugs Product Scope
1.2 Blood-Brain Barrier Transport Drugs Segment by Type
1.2.1 Global Blood-Brain Barrier Transport Drugs Sales by Type (2020-2026)
1.2.2 Carrier-mediated Transport
1.2.3 Receptor-mediated Transport
1.2.4 Absorptive-mediated Transport
1.2.5 Active Efflux Transport
1.2.6 Others
1.3 Blood-Brain Barrier Transport Drugs Segment by Application
1.3.1 Global Blood-Brain Barrier Transport Drugs Sales Comparison by Application (2020-2026)
1.3.2 Alzheimer’s Disease
1.3.3 Epilepsy
1.3.4 Parkinson’s Disease
1.3.5 Multiple Sclerosis
1.3.6 Hunter’s Syndrome
1.3.7 Brain Cancer
1.3.8 Others
1.4 Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Blood-Brain Barrier Transport Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Blood-Brain Barrier Transport Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Blood-Brain Barrier Transport Drugs Price Trends (2015-2026)

2 Blood-Brain Barrier Transport Drugs Estimate and Forecast by Region
2.1 Global Blood-Brain Barrier Transport Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Blood-Brain Barrier Transport Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Blood-Brain Barrier Transport Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.3 China Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
2.4.6 India Blood-Brain Barrier Transport Drugs Estimates and Projections (2015-2026)
3 Global Blood-Brain Barrier Transport Drugs Competition Landscape by Players
3.1 Global Top Blood-Brain Barrier Transport Drugs Players by Sales (2015-2020)
3.2 Global Top Blood-Brain Barrier Transport Drugs Players by Revenue (2015-2020)
3.3 Global Blood-Brain Barrier Transport Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood-Brain Barrier Transport Drugs as of 2019)
3.4 Global Blood-Brain Barrier Transport Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Blood-Brain Barrier Transport Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Blood-Brain Barrier Transport Drugs Players (Opinion Leaders)
4 Global Blood-Brain Barrier Transport Drugs Market Size by Type
4.1 Global Blood-Brain Barrier Transport Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Blood-Brain Barrier Transport Drugs Price by Type (2015-2020)
4.2 Global Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Blood-Brain Barrier Transport Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Blood-Brain Barrier Transport Drugs Price Forecast by Type (2021-2026)
5 Global Blood-Brain Barrier Transport Drugs Market Size by Application
5.1 Global Blood-Brain Barrier Transport Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Blood-Brain Barrier Transport Drugs Price by Application (2015-2020)
5.2 Global Blood-Brain Barrier Transport Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Blood-Brain Barrier Transport Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Blood-Brain Barrier Transport Drugs Price Forecast by Application (2021-2026)

6 United States Blood-Brain Barrier Transport Drugs Market Facts & Figures
6.1 United States Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
6.2 United States Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
6.3 United States Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)

7 Europe Blood-Brain Barrier Transport Drugs Market Facts & Figures
7.1 Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)

8 China Blood-Brain Barrier Transport Drugs Market Facts & Figures
8.1 China Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
8.2 China Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
8.3 China Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)

9 Japan Blood-Brain Barrier Transport Drugs Market Facts & Figures
9.1 Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)

10 Southeast Asia Blood-Brain Barrier Transport Drugs Market Facts & Figures
10.1 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)

11 India Blood-Brain Barrier Transport Drugs Market Facts & Figures
11.1 India Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2015-2020)
11.2 India Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2015-2020)
11.3 India Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Blood-Brain Barrier Transport Drugs Business
12.1 Cyclenium
12.1.1 Cyclenium Corporation Information
12.1.2 Cyclenium Business Overview
12.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Products Offered
12.1.5 Cyclenium Recent Development
12.2 BioAdvance
12.2.1 BioAdvance Corporation Information
12.2.2 BioAdvance Business Overview
12.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Products Offered
12.2.5 BioAdvance Recent Development
12.3 EIP Pharma
12.3.1 EIP Pharma Corporation Information
12.3.2 EIP Pharma Business Overview
12.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.3.5 EIP Pharma Recent Development
12.4 Bioasis
12.4.1 Bioasis Corporation Information
12.4.2 Bioasis Business Overview
12.4.3 Bioasis Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bioasis Blood-Brain Barrier Transport Drugs Products Offered
12.4.5 Bioasis Recent Development
12.5 Immune Pharmaceuticals
12.5.1 Immune Pharmaceuticals Corporation Information
12.5.2 Immune Pharmaceuticals Business Overview
12.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Products Offered
12.5.5 Immune Pharmaceuticals Recent Development
12.6 AZ Therapies
12.6.1 AZ Therapies Corporation Information
12.6.2 AZ Therapies Business Overview
12.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Products Offered
12.6.5 AZ Therapies Recent Development
12.7 Palobiofarma
12.7.1 Palobiofarma Corporation Information
12.7.2 Palobiofarma Business Overview
12.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Palobiofarma Blood-Brain Barrier Transport Drugs Products Offered
12.7.5 Palobiofarma Recent Development
12.8 Bach Pharma
12.8.1 Bach Pharma Corporation Information
12.8.2 Bach Pharma Business Overview
12.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.8.5 Bach Pharma Recent Development
12.9 BrainsGate
12.9.1 BrainsGate Corporation Information
12.9.2 BrainsGate Business Overview
12.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Products Offered
12.9.5 BrainsGate Recent Development
12.10 CarThera
12.10.1 CarThera Corporation Information
12.10.2 CarThera Business Overview
12.10.3 CarThera Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CarThera Blood-Brain Barrier Transport Drugs Products Offered
12.10.5 CarThera Recent Development
12.11 Dainippon Sumitomo Pharma
12.11.1 Dainippon Sumitomo Pharma Corporation Information
12.11.2 Dainippon Sumitomo Pharma Business Overview
12.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.11.5 Dainippon Sumitomo Pharma Recent Development
12.12 Fluorinov Pharma
12.12.1 Fluorinov Pharma Corporation Information
12.12.2 Fluorinov Pharma Business Overview
12.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Products Offered
12.12.5 Fluorinov Pharma Recent Development
12.13 Fondazione Telethon
12.13.1 Fondazione Telethon Corporation Information
12.13.2 Fondazione Telethon Business Overview
12.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Fondazione Telethon Blood-Brain Barrier Transport Drugs Products Offered
12.13.5 Fondazione Telethon Recent Development
12.14 Minoryx
12.14.1 Minoryx Corporation Information
12.14.2 Minoryx Business Overview
12.14.3 Minoryx Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Minoryx Blood-Brain Barrier Transport Drugs Products Offered
12.14.5 Minoryx Recent Development
12.15 NewGen Therapeutics
12.15.1 NewGen Therapeutics Corporation Information
12.15.2 NewGen Therapeutics Business Overview
12.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Products Offered
12.15.5 NewGen Therapeutics Recent Development

13 Blood-Brain Barrier Transport Drugs Manufacturing Cost Analysis
13.1 Blood-Brain Barrier Transport Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs
13.4 Blood-Brain Barrier Transport Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Blood-Brain Barrier Transport Drugs Distributors List
14.3 Blood-Brain Barrier Transport Drugs Customers

15 Market Dynamics
15.1 Blood-Brain Barrier Transport Drugs Market Trends
15.2 Blood-Brain Barrier Transport Drugs Opportunities and Drivers
15.3 Blood-Brain Barrier Transport Drugs Market Challenges
15.4 Blood-Brain Barrier Transport Drugs Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【掲載企業】

Cyclenium、BioAdvance、EIP Pharma、Bioasis、Immune Pharmaceuticals、AZ Therapies、Palobiofarma、Bach Pharma、BrainsGate、CarThera、Dainippon Sumitomo Pharma、Fluorinov Pharma、Fondazione Telethon、Minoryx、NewGen Therapeutics

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の血液脳関門輸送薬市場レポート2020年(Global Blood-Brain Barrier Transport Drugs Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。